Clinical Partners — Johnston, Rhode Island

Clinical Partners is a clinical research site located in Johnston, Rhode Island, United States 02919.

Crixeo Clinical Trials Trust Score: 29/100 (FAILING). This profile has not yet been claimed by the site owner.

Clinical Partners has participated in 86 clinical trials with 6 currently active.

Therapeutic areas: Genital Psoriasis, Psoriasis, Acne Vulgaris.

Sponsors: Eli Lilly and Company, Intrepid Therapeutics, Inc., Stiefel, a GSK Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Johnston

Browse all research sites in Rhode Island · View every site in Johnston

• Research Site
• GSK Investigational Site
• Novartis Investigative Site
• Study Site 345
• Local Institution
• Foamix Investigational Site # 105
• Arcutis Clinical Site 101
• Forest Investigative Site 1144
• Dermavant Investigative Site
• Vanda Investigational Site
• Galderma Investigational Site

Sponsor Feasibility Report

Trust Score: 29/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Partners?

Clinical Partners has a Crixeo Trust Score of 29/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Partners conducted?

Clinical Partners has 86 clinical trials on record, with 6 currently active. Their work covers Genital Psoriasis, Psoriasis, Acne Vulgaris.

Is Clinical Partners accredited by Crixeo Clinical Trials?

Clinical Partners has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Clinical Partners?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.